Synaptogenix, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 12.61 million compared to USD 12.7 million a year ago. Basic loss per share from continuing operations was USD 2.51 compared to USD 12.03 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.23 USD | -0.47% |
|
-8.24% | -37.77% |
May. 15 | Synaptogenix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 09 | Synaptogenix, Inc. acquired Unknown Stake in Psyga Bio Ltd from Cannasoul Analytics Ltd. | CI |
1st Jan change | Capi. | |
---|---|---|
-37.77% | 5.22M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- SNPX Stock
- News Synaptogenix, Inc.
- Synaptogenix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021